AbCellera Biologics Balance Sheet Health
Financial Health criteria checks 6/6
AbCellera Biologics has a total shareholder equity of $1.1B and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.5B and $333.2M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$698.02m |
Equity | US$1.13b |
Total liabilities | US$333.18m |
Total assets | US$1.46b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 8QQ's short term assets ($813.9M) exceed its short term liabilities ($104.9M).
Long Term Liabilities: 8QQ's short term assets ($813.9M) exceed its long term liabilities ($228.3M).
Debt to Equity History and Analysis
Debt Level: 8QQ is debt free.
Reducing Debt: 8QQ has no debt compared to 5 years ago when its debt to equity ratio was 38.1%.
Debt Coverage: 8QQ has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 8QQ has no debt, therefore coverage of interest payments is not a concern.